What is Evotaz?

Evotaz is intended to treat human immunodeficiency virus (HIV) infection. It combines two drugs, atazanavir (a protease inhibitor) and cobicistat (a CYP3A inhibitor). These drugs prevent HIV from reproducing and slow damage to the immune system, but do not cure the infection. Evotaz is a once-daily tablet, taken with food. It is not recommended for patients with liver impairment or end-stage kidney disease with hemodialysis, or for children under three months of age; pregnant women may be prescribed Evotaz if the benefits are thought to outweigh risks. Evotaz may interact with a number of other drugs, including rifampin, lovastatin, St. John's wort, and alfuzosin; patients should make sure their doctor knows all drugs and supplements they are taking. Side effects include allergic reaction; nausea; jaundice; a blistering, peeling rash; weight gain around the neck, upper back, breast, and face; lightheadedness; and urination problems. Alert your doctor if you have any of these.